← Open Payments lookup

STEPHANIE SILVERMAN: Open Payments

NPI 1679941363 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,475 in 88 payments from 21 companies in 2025. Trend: 2023 $1,691 · 2024 $1,636 · 2025 $1,475

Food & beverage: $1,475
CompanyPaymentsAmount
Lilly USA, LLC8$220
AstraZeneca Pharmaceuticals LP13$200
GlaxoSmithKline, LLC.18$163
Novartis Pharmaceuticals Corporation10$160
ABBVIE INC.7$118
Novo Nordisk Inc6$104
Bayer Healthcare Pharmaceuticals Inc.4$87
Corcept Therapeutics2$67
Boehringer Ingelheim Pharmaceuticals, Inc.4$66
PFIZER INC.3$46

Products named: LEQVIO, TRELEGY ELLIPTA, AIRSUPRA, KISUNLA, Rybelsus, UBRELVY, Kerendia, MOUNJARO.

Industry payments across TX — which companies pay providers there.